Prognostic factors after liver resection for hepatocellular carcinoma: A single-center experience from China

American Journal of Surgery

Volumn 203, Issue 6, 2012, Pages 741-750

  Liu, Liguo ^a,b   Miao, Ruoyu ^a   Yang, Huayu ^a   Lu, Xin ^a   Zhao, Yi ^c   Mao, Yilei ^a   Zhong, Shouxian ^a   Huang, Jiefu ^a   Sang, Xinting ^a   Zhao, Haitao ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CANCER HOSPITAL   (China)

^c INSTITUTE OF COMPUTING TECHNOLOGY   (China)

Author keywords

French scoring system; Hepatectomy; Prognosis; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHINA; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME; TUMOR VOLUME; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84861581117     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2011.05.010     Document Type: Article

References (38)

1. J.M. Llovet, J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 Suppl 1 2008 S20 S37
2. The Cancer of the Liver Italian Program (CLIP) Investigators A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 1998 751 755
3. J.M. Llovet, C. Brú, J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
4. S. Chevret, J.C. Trinchet, D. Mathieu A new prognostic classification for predicting survival in patients with hepatocellular carcinoma Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire J Hepatol 31 1999 133 141
5. T.W. Leung, A.M. Tang, B. Zee Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients Cancer 94 2002 1760 1769
6. M. Kudo, H. Chung, Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 2003 207 215
7. S.B. Edge, D.R. Byrd, C.C. Compton AJCC Cancer Staging Manual 7th ed. 2010 Springer New York 237 246
8. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
9. S. Ko, H. Kanehiro, M. Hisanaga Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma Br J Surg 89 2002 57 62
10. M. Kaibori, M. Ishizaki, T. Saito Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas Am J Surg 198 2009 39 45
11. C.S. Lee, J.L. Sung, L.Y. Hwang Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma Surgery 99 1986 481 490
12. J.M. Regimbeau, R. Kianmanesh, O. Farges Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma Surgery 131 2002 311 317
13. I. Ikai, S. Arii, M. Kojiro Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey Cancer 101 2004 796 802
14. M. Shi, R.P. Guo, X.J. Lin Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial Ann Surg 245 2007 36 43
15. Y. Matsui, N. Terakawa, S. Satoi Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection Arch Surg 142 2007 596 603
16. K. Tanaka, H. Shimada, C. Matsumoto Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma Surgery 143 2008 607 615
17. D. Dahiya, T.J. Wu, C.F. Lee Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience Surgery 147 2010 676 685
18. R.T. Poon, S.T. Fan, I.O. Ng Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal Ann Surg 231 2000 544 551
19. H.B. El-Serag, J.A. Marrero, L. Rudolph Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 2008 1752 1763
20. S. Ko, Y. Nakajima, H. Kanehiro Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy Result of multivariate analysis Ann Surg 224 1996 591 595
21. E.J. Mullin, M.S. Metcalfe, G.J. Maddern How much liver resection is too much? Am J Surg 190 2005 87 97
22. A.H. Kwon, Y. Matsui, Y. Kamiyama Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival Cancer 91 2001 771 778
23. S. Sugita, A. Sasaki, K. Iwaki Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study Eur J Surg Oncol 34 2008 339 345
24. H. Shiba, Y. Ishida, S. Wakiyama Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection J Gastrointest Surg 13 2009 1636 1642
25. H.J. Nielsen Detrimental effects of perioperative blood transfusion Br J Surg 82 1995 582 587
26. E. Dixon, I. Datta, F.R. Sutherland Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol 99 2009 508 512
27. S.G. Delis, J. Madariaga, A. Bakoyiannis Current role of bloodless liver resection World J Gastroenterol 13 2007 826 829
28. C.N. Yeh, M.F. Chen, W.C. Lee Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis J Surg Oncol 81 2002 195 202
29. L. Qiang, L. Huikai, K. Butt Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma World J Surg 30 2006 439 445
30. J.M. Llovet, J. Bustamante, A. Castells Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 1999 62 67
31. L. Aldrighetti, C. Pulitanò, M. Catena Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion Ann Surg Oncol 16 2009 1254
32. J. Shi, E.C. Lai, N. Li Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus Ann Surg Oncol 17 2010 2073 2080
33. X.P. Chen, F.Z. Qiu, Z.D. Wu Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma Ann Surg Oncol 13 2006 940 946
34. S.L. Chan, F.K. Mo, P.J. Johnson New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy J Clin Oncol 27 2009 446 452
35. R.D. Kim, A.I. Reed, S. Fujita Consensus and controversy in the management of hepatocellular carcinoma J Am Coll Surg 205 2007 108 123
36. J.M. Llovet, A. Burroughs, J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
37. U. Cillo, A. Vitale, F. Grigoletto et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 2006 723 731
38. J.A. Marrero, R.J. Fontana, A. Barrat Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort Hepatology 41 2005 707 716